The antitumor and drug resistant mechanisms of chemotherapy in non-small cell lung cancer cells
博士 === 國立中興大學 === 生物醫學研究所 === 103 === Lung cancer is one of leading causes of cancer death in Taiwan. Non-small cell lung cancer (NSCLC) compromises more than 85-90% of all lung cancers. Systemic therapy with chemotherapy is an important part of therapy in NSCLC patients. Chemotherapy provides surv...
Main Authors: | Kun-Chieh Chen, 陳焜結 |
---|---|
Other Authors: | 陳健尉 |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/87015347589704602123 |
Similar Items
-
Resistance to chemotherapy in non-small cell lung cancer
by: Berrieman, Helen Katherine
Published: (2004) -
Antitumor Activity of Acriflavine in Non-Small Cell Lung Cancer Cells
by: Yu-Jie Lin, et al.
Published: (2014) -
Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer
by: Maryna Bondarenko, et al.
Published: (2021-05-01) -
Novel mechanisms of resistance to EGFR inhibitory drugs in non-small cell lung cancer
by: Cowell, C. F.
Published: (2012) -
The Cellular and Molecular Mechanisms of Pemetrexed-mediated Antitumor Effects in Human Non-small-cell Lung Cancer Cells
by: Tsung-Ying Yang, et al.
Published: (2013)